Browsing by Autor "Jeannete Zurita"

Now showing 1 - 4 of 4

Antimicrobial stewardship programs in adult intensive care units in Latin America: Implementation, assessments, and impact on outcomes
(Cambridge University Press, 2021) Rodolfo Quirós; Ana C. Bardossy; Patricia Angeleri; Jeannete Zurita; Washington René Alemán Espinoza; Marcelo Carneiro; S Del Guerra; Julio C. Medina; Ximena Castañeda Luquerna; Alexander Guerra
MS-ICUs with more comprehensive ASPs showed significant improvement in antimicrobial utilization.
Emergence of Coccidioides posadasii in an asymptomatic Ecuadorian patient with diabetes: A case report
(2024) Zanny Bastidas; Jeannete Zurita; Gabriela Sevillano; Jesus-Elias Dawaher; P. Mateos Cáceres; César Delgado
Coccidioidomycosis is a potentially serious but poorly studied mycosis in Ecuador. It is not a notifiable infection; therefore, its true incidence and prevalence in Ecuador remain unknown. Because primary lung disease due to coccidioidomycoses is typically self-limiting, it does not usually require treatment. Here, we present the first case of <i>Coccidioides posadasii</i> infection in an asymptomatic patient with diabetes without a history of travel to an endemic area. This is the first case reported in Ecuador in the last half-century.
Impact of Antimicrobial Stewardship Programs in Latin American Adult Intensive Care Units: PROA-LATAM Project
(Cambridge University Press, 2020) Rodolfo Quirós; Patricia Angeleri; Jeannete Zurita; Washington Alemán; Marcelo Carneiro; S Del Guerra; Julio C. Medina; Ximena Castañda Luquerna; Alexander Guerra; Silvio Vega
Background: Antimicrobial stewardship programs (ASPs) are useful in improving clinical outcomes in a cost-effective way and in reducing antimicrobial resistance. Objective: We sought to determine the impact of ASP in adult medical-surgical intensive care units (MS-ICUs). Methods: A multicenter study, in 77 MS-ICUs of 9 Latin-American countries, was conducted along 12 months (July 2018–June 2019). A self-assessment survey using a tool based on CDC recommendations (0–100 scale) was performed at the beginning, after 6 months, and at the end of the study. The impact of ASP was evaluated monthly using the following indicators: antimicrobial consumption (defined daily doses [DDD] per 100 patient days), appropriateness of antimicrobial prescriptions (percentage of total prescriptions), crude mortality rate (events per 100 discharges), and hospital-acquired multidrug-resistant microorganisms (MDRs) and Clostridioides difficile infections (CDI events per 1,000 patient days). These indicators were compared between MS-ICUs that reached the 75th percentile and those that maintained the 25th percentile at the final self-assessment. Results: Of all indicators evaluated, only surgical prophylaxis ≤24 hours, vancomycin therapeutic monitoring, and aminoglycosides (1 dose per day) did not show significant differences between MS-ICUs at the 75th percentile and the 25th percentile. CDI events were significantly higher at the 75th percentile MS-ICUs, probably related to better detection of C. difficile (Table 1). Conclusions: This study confirmed that MS-ICUs with more comprehensive ASPs had significantly better indicators. Funding: Proprietary Organization: MERCK Disclosures: None
Recent Progress on Enterotoxigenic E. coli (ETEC) and Antibiotic Resistance in Pathogenic E. coli
(2023) Enrique Joffré; Jeannete Zurita; Carla Calderon Toledo; Sergio Gutiérrez-Cortez